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ABSTRACT
OBJECTIVE: To characterize the activities of clinical nature developed by pharmacists in basic 
health units and their participation in educational activities aiming at health promotion.
METHODS: This article is part of the Pesquisa Nacional sobre Acesso, Utilização e Promoção do 
Uso Racional de Medicamentos – Serviços, 2015 (PNAUM – National Survey on Access, Use and 
Promotion of Rational Use of Medicines – Services, 2015), a cross-sectional and exploratory study, 
of evaluative nature, consisting of a survey of information in a representative sample of cities, 
stratified by the Brazilian regions that constitute domains of study, and a subsample of primary 
health care services. The interviewed pharmacists (n=285) were responsible for the delivery 
of medicines and were interviewed in person with the use of a script. The characterization 
of the activities of clinical nature was based on information from pharmacists who declared 
to perform them, and on participation in educational activities aiming at health promotion, 
according to information from all pharmacists. The results are presented in frequency and their 
95% confidence intervals.
RESULTS: From the interviewed subjects, 21.3% said they perform activities of clinical nature. 
Of these, more than 80% considered them very important; the majority does not dispose of specific 
places to perform them, which hinders privacy and confidentiality in these activities. The main 
denominations were “pharmaceutical guidance” and “pharmaceutical care.” The registration of 
activities is mainly made in the users’ medical records, computerized system, and in a specific 
document filed at the pharmacy, impairing the circulation of information among professionals. 
Most pharmacists performed these activities mainly along with physicians and nurses; 24.7% 
rarely participated in meetings with the health team, and 19.7% have never participated.
CONCLUSIONS: Activities of clinical nature performed by pharmacists in Brazil are still 
incipient. The difficulties found point out to the professionals’ improvisation and effort. The 
small participation in educational activities of health promotion indicates little integration of 
pharmacists with the health team and of pharmaceutical services with other health actions.
DESCRIPTORS: Pharmacists. Pharmaceutical Care. Pharmaceutical Services. Primary Health 
Care. Health Services Research. Unified Health System.
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INTRODUCTION
Drug-related morbidity and mortality  has been pointed out as an important public health 
problem around the world6,14,17. In Brazil, studies have shown the impact on society and 
on the Brazilian Unified Health System (SUS)3,25. Among the drug-related problems, it is 
possible to highlight those related to indication, effectiveness, safety, and adherence. These 
problems cause morbidity and mortality related to these technologies, which result in high 
social impact within the clinical, humanistic, and economic contexts. The main risk factors 
associated with the occurrence of these problems include age, presence of comorbidities, 
and polipharmacotherapy10,14,25. Preventing and minimizing this impact require actions that 
interfere in the process of use of medicines by users, by managing the drug therapy6,17. These 
are important challenges of the current pharmaceutical services agenda in Brazil. 
In several countries5,7,9,21,23,27, pharmaceutical carea has been assumed as strategic policy for 
reducing the impact of drug-related morbidity and mortality 6,12,17. In Brazil, it is part of the 
Política Nacional de Assistência Farmacêutica (PNAF – National Policy of Pharmaceutical 
Services). However, research on this subject are scarce, even in studies that discuss 
pharmaceutical policies that prescribe these practices in their devices, as an example of 
the specialized component of pharmaceutical services. The studies that investigate such 
activities take place in SUS and their results are also incipient.
The subject of pharmaceutical care finds some difficulties, especially regarding the 
understanding of its meaning. Worldwide, the definition adopted by Hepler and Strand10 
(1990) is considered a consensual milestone. However, in Brazil, what is called pharmaceutical 
care assumes different meanings in what could be called “world of science” and in how the 
policies in the field of pharmaceutical services understand it. The differences are in the 
epistemological plan and are repeated during practice. 
The names that have been widely used among pharmacists to designate services of clinical 
nature are: cognitive pharmaceutical services, pharmaceutical consultation, pharmaceutical 
guidance, patient education, clinical pharmacy, and pharmaceutical care/drug therapy 
follow-up/management of drug therapy. In several countries, the designation adopted for 
activities of clinical nature, the way they are performed, and the organizational aspects 
translate (or not) the elements that reveal the philosophical basis, the modus operandi, and 
the management aspects of these activities17,19. 
Beyond the “cloudy weather”17 that involves what is called pharmaceutical care, in this study 
we understand as pharmaceutical activity of clinical nature all activities executed directly with 
the user and that has the purpose to meet the patients’ needs regarding the use of medicines 
and to express philosophical elements. According to Cipolle, Strand, and Morley6 (p. 73), “the 
philosophy of pharmaceutical care includes several elements. It starts with the affirmation of a social 
necessity; it continues with a patient-centered approach to meet this need; it has as central element 
the care to another person by the development and maintenance of a therapeutic relationship, and 
concludes with a description of the professional’s actual responsibilities.” Furthermore, a process 
of formal care, i.e., the modus operandi of care and management aspects.
There are, in Brazil, specific pharmaceutical policies that attribute to the pharmacist the 
exercise of activities of clinical nature – named in PNAF as pharmaceutical care. In addition, 
one can observe gaps regarding information on the performance or not of these activities in 
the primary care in SUS. Considering this, this study aimed to characterize the activities of 
clinical nature developed by pharmacists in basic health units of SUS and their participation 
in educational activities aiming at health promotion.
METHODS
This study is part of the Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso 
Racional de Medicamentos – Serviços, 2015 (PNAUM – National Survey on Access, 
a Pharmaceutical care in the 
National Policy of Pharmaceutical 
Services is defined as an action 
of pharmaceutical services, 
considered a model of the practice 
performed by the pharmacist. 
In this policy, the modus 
operandi of this practice includes 
the direct interaction of the 
pharmacist with the user, with the 
objective of providing a rational 
pharmacotherapy and obtaining 
of defined and measurable 
clinical results, in addition to 
understanding this practice as 
important to the completeness of 
the health actions.
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Use and Promotion of Rational Use of Medicines – Services, 2015), whose goal was to 
characterize the organization of pharmaceutical services in the primary health care of 
SUS, aiming to promote the access and rational use of medicines, as well as to identify 
and discuss factors that interfere in the consolidation of pharmaceutical services in 
the municipal scope. 
PNAUM is a cross-sectional exploratory study, with evaluative nature, consisting of 
a survey of information in a representative sample of primary health care services in 
representative cities in the regions of Brazil. Several populations were considered in the 
sampling, with samples stratified by the regions that constitute the domains of study. 
Face-to-face interviews were carried out with users, physicians, and those responsible 
for the delivery of medicines in the primary health care services of SUS, in addition to 
observation of pharmaceutical services and telephone interviews with the professionals 
responsible for pharmaceutical services and with the public administrators of the selected 
cities. The methodology of PNAUM, as well as the sampling process, are described in detail 
by Álvares et al.1
In this article, only pharmacists were selected among those responsible for the delivery of 
medicines. This is a descriptive and exploratory study with selected variables.
The characterization of pharmaceutical activities of clinical nature occurred based on the 
information provided by pharmacists who informed to perform this activity when answering 
the following question: “Do you perform any activity of clinical character?” From the 
affirmative to this question, we sought to identify the names and the importance attributed 
by pharmacists who declared to carry out the activity; among the others, the reasons for 
not carrying out those activities. 
The relationship of the names of the activities of clinical nature included in the interview 
scripts considered those most used in publications of literature review: pharmaceutical 
care, drug therapy follow-up, clinical pharmacy, pharmaceutical consultation, 
pharmaceutical guidance, pharmaceutical assistance. The script also had a space for 
“other names,” which were little used and were not analyzed in this article. Furthermore, 
we included questions aiming to set up the presence of philosophical elements6,16 of the 
mentioned activity and of the process of care provided to the user. In addition, elements 
of a management system with human and material resources were organized, necessary 
to carry out the activities.
Considering the different conceptions of activities of clinical nature2,6,17, the participation in 
educational activities/health promotion activities was sought, as they are activities of diverse 
nature of dispensation or management functions specific to pharmaceutical activities. 
The data were analyzed using the software SPSS® version 21. The analyses considered the 
sampling weights and the structure of the analysis plan for complex samples. A descriptive 
analysis of the variables used in the study was performed, presented according to the regions 
of Brazil with a 95% confidence interval.  
PNAUM was approved by the National Research Ethics Committee, by Opinion no. 
398.131/2013. All participants signed an informed consent form.
RESULTS 
We interviewed 1,139 individuals responsible for the delivery of medicines, of which 285 
were pharmacists (32.7%); 106, pharmacy assistants (10.6%); 141, nurses (11.5%); 115, nursing 
technicians (8.3%); and 492 reported other professions or occupations (37%). From all the 
interviewed pharmacists, 79 (21.4%) said they perform activities of clinical nature. 
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Among the 285 pharmacists interviewed, more than 3/4 were aged between 30 and 59 
years; most were women (except in the Midwest); and most had latu sensu graduate level 
(specialization addressed to professional practice), with the highest percentage in the 
Northeast  (Table 1).
Table 2 shows that, of the total pharmacists interviewed, just over 1/5 stated performing 
some activity of clinical nature. The highest percentage was achieved in the Northeast region 
(47.5%) and the lowest in the South (6.0%). 
Table 1. Sociodemographic characteristics of pharmacists of primary health care according to the regions of Brazil. National Survey on 
Access, Use and Promotion of Rational Use of Medicines, 2015. (n = 285)
Variable
North Northeast Midwest Southeast South Brazil
% (IC95%) % (IC95%) % (IC95%) % (IC95%) % (IC95%) % (IC95%)
Sex
Female 68.5 (54.9–79.6) 69.6 (29.1–92.7) 49.9 (29.1–70.7) 60.9 (40.9–77.8) 84.8 (70.1–92.9) 64.6 (50.8–76.3)
Male 31.5 (20.4–45.1) 30.4 (7.3–70.9) 50.1 (29.3–70.9) 39.1 (22.2–59.1) 15.2 (7.1–29.9) 35.4 (23.7–49.2)
Skin color
White 65.2 (50.1–77.8) 79.6 (45.2–94.8) 77.6 (61.8–88.1) 82.6 (69.9–90.6) 93.5 (77.4–98.3) 82.8 (74.7–88.6)
Black – 11.3 (1.6–49.8) 1.4 (0.3–6.2) 0.7 (0.2–2.0) – 1.5 (0.6–4.2)
Yellow – – – 1.7 (0.3–9.5) – 1.0 (0.2–6.4)
Mixed race 33.6 (21.1–48.8) 9.1 (4.2–18.7) 21.0 (10.7–37) 15.1 (7.3–28.4) 6.5 (1.7–22.6) 14.6 (9.1–22.6)
Indigenous 1.2 (0.2–8.3) – – – – 0.1 (0–0.4)
Marital status 
Single 32.7 (17.8–52.0) 10.0 (1.2–50.8) 61.1 (39.6–79.0) 32.2 (20.1–47.2) 37.7 (20.2–59.2) 34.1 (24.9–44.6)
Married 59.2 (40.8–75.3) 47.6 (9.5–88.7) 37.5 (19.7–59.5) 57.9 (41.7–72.6) 55.7 (34.3–75.1) 54.7 (42.7–66.1)
Stable union 7.0 (2.4–18.2) 1.9 (0.2–13.3) 0.2 (0–1.7) 4.7 (1.0–19.0) 4.4 (1.2–15.2) 4.0 (1.3–11.6)
Divorced 1.2 (0.2–8.3) 40.6 (5.5–89) 1.2 (0.2–8.5) 4.2 (2.0–8.6) 2.2 (0.3–12.7) 6.6 (2.3–17.9)
Widower – – – 1.0 (0.2–4.4) – 0.6 (0.1–2.9)
Age group (years)
18 - 29 36.0 (22–52.9) 9.0 (0.9–51.7) 36.3 (17.6–60.2) 23.8 (12.8–39.9) 19.7 (8.9–38) 23.6 (15.6–34.1)
30 - 59 64.0 (47.1–78) 91.0 (48.3–99.1) 58.9 (34.3–79.6) 74.1 (58.3–85.4) 76.5 (56.8–88.9) 74.0 (63.5–82.3)
60 or more – – 4.9 (0.6–29.5) 2.1 (0.8–5.8) 3.9 (0.5–24.3) 2.4 (1.0–5.5)
Education level
Lato sensu Specialization 38.3 (24.9–54.6) 65.7 (17.3–94.6) 35.1 (14.9–62.5) 35.2 (21.5–51.8) 51.2 (29.9–72.1) 40.4 (29.4–52.6)
Master’s or Doctorate degree 2.4 (0.6–9.2) – 7.3 (1.6–27.2) 12.6 (2–50.2) 2.5 (0.4–12.3) 9.0 (1.8–34.2)
Source: PNAUM – Services, 2015.
Table 2. Performance of activities of clinical nature, name, and importance given by pharmacists of primary health care, according to the 
regions of Brazil. National Survey on Access, Use and Promotion of Rational Use of Medicines, 2015.
Dimension/Variable
North Northeast Midwest Southeast South Brazil
% (IC95%) % (IC95%) % (IC95%) % (IC95%) % (IC95%) % (IC95%)
Activities of clinical nature
Perform them (n = 79) 29.8 (18.3–44.8) 47.5 (11.1–86.8) 20.2 (5.9–50.8) 21.2 (12.3–33.9) 6.0 (1.5–21.5) 21.3 (13.6–31.9)
Do not perform them (n = 206) 69.7 (55.2–81.7) 52.5 (13.2–88.9) 79.8 (49.2–94.1) 78.8 (66.1–87.7) 94.0 (78.5–98.5) 78.6 (68.1–86.4)
Reasons for not performing them (n = 206)
Do not possess the necessary physical space 56.0 (37.0–73.4) 82.8 (29.3–98.2) 56.3 (28.4–80.7) 42.1 (24.4–62.1) 43.7 (23.3–66.5) 46.7 (33.4–60.5)
Do not have enough time 49.1 (29.9–68.7) 19.0 (2.3–70.5) 58.6 (36.8–77.5) 50.6 (30.9–70) 28.7 (15.9–46.2) 45.4 (32.0–59.6)
Was never asked to perform them 44.1 (26.0–64.0) 84.4 (66.9–93.6) 58.1 (30.5–81.4) 49.9 (29.9–69.9) 52.7 (30.1–74.3) 53.0 (38.6–67.0)
Other 7.9 (1.8–28.4) – 15.2 (5.6–35.2) 7.4 (2.7–18.9) 21.3 (9.2–41.8) 10.4 (5.8–17.8)
Naming (n = 79) 
Pharmaceutical care 61.4 (36.2–81.7) 2.0 (0.1–21.6) 29.4 (5.3–75.8) 45.8 (23.2–70.3) 35.4 (4.3–87.1) 36.2 (18.5–58.7)
Drug therapy follow-up 3.4 (0.5–21.2) – – 4.7 (0.8–22.8) – 3.1 (0.6–14.5)
Clinical pharmacy – 4.8 (0.4–41.5) – 1.4 (0.3–5.8) – 1.8 (0.5–6.2)
Pharmaceutical consultation 10.9 (1.6–48.4) 2.0 (0.1–21.6) 66.0 (19.1–94.1) 16.0 (6.2–35.4) – 17.1 (6.8–36.9)
Pharmaceutical guidance 24.3 (10.4–47.2) 91.3 (53.0–99.0) 4.6 (0.4–34.9) 25.6 (9.6–52.6) 64.6 (12.9–95.7) 37.9 (17.2–64.2)
Pharmaceutical assistance – – – 6.5 (1.7–21.6) – 4.0 (1.1–13.9)
Importance (n = 79)
Very important 95.9 (75.4–99.5) 98.0 (78.4–99.9) 90.8 (56.9–98.7) 83.2 (62.1–93.8) 35.4 (4.3–87.1) 85.5 (69.6–93.8)
Important 4.1 (0.5–24.6) 9.2  (1.3–43.1) 16.8 (6.2–37.9) 64.6 (12.9–95.7) 14.2 (6.0–30.0)
Not important – 2.0 (0.1–21.6) – – – 0.4 (0.1–2.8)
Source: PNAUM – Services, 2015.
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The main reasons alleged by pharmacists for not performing such activities were: never 
having been requested, not disposing of the physical space, and not having enough time. 
Other mentioned reasons include the absence of specific training, lack of encouragement by 
the city, absence of physical structure, insufficient personnel on the pharmacy, among others.
The main names assigned to these activities were: “pharmaceutical guidance” (Northeast and 
South) and “pharmaceutical care” (North and Southeast). In the Midwest region, the most 
frequent name was “pharmaceutical consultation”; the name “pharmaceutical assistance” 
was observed only in the Southeast; and “clinical pharmacy,” only in the South and Southeast. 
It was not possible to investigate the explaining factors of these differences.
The most frequent functions performed at the same time with activities of clinical nature 
were: dispensing of medicines (93.6%), technical responsibility by the pharmacy (90.5%), 
supervision of other employees of the pharmacy (74.5%), and activities with the health 
team (61.2%). 
In the Northeast, 100% of the pharmacists who claimed to perform activities of clinical nature 
reported they also perform dispensing of medicines, while in the Midwest, dispensing was 
declared only by 32.9% of the pharmacists who performed clinical activities. When questioned 
about the importance they assigned to such activities, most pharmacists who performed 
activities of clinical nature considered them very important (85.5%) or important (14.2%). 
According to Table 3, the conditions and ways of conducting the pharmaceutical activities of 
clinical nature varied between regions. Most pharmacists said they perform such activities 
mainly along with physicians and nurses. Among all the pharmacists interviewed in the 
study, 1/4 of them stated they rarely participate in meetings with the health team and 1/5 
said they have never participated (Table 5). 
The study identified that, in Brazil, the registration of activities of clinical nature is mainly 
made in the user’s medical record, in a computerized system, and in a specific document 
filed at the pharmacy, in that order. The  highest percentages of registration of these activities 
Table 3. Characterization of the activities of clinical nature performed by pharmacists of primary health care, according to the regions of 
Brazil. National Survey on Access, Use and Promotion of Rational Use of Medicines, 2015. (n = 79)
Dimension/Variable
North Northeast Midwest Southeast South Brazil
% (IC95%) % (IC95%) % (IC95%) % (IC95%) % (IC95%) % (IC95%)
To whom they are offered
All users 32.0 (14.5–56.6) 85.4 (39.6–98.1) 12.0 (1.7–51.3) 49.5 (26.4–72.9) 4.0 (0.4–32.5) 49.8 (27.9–71.8)
Users who require it 33.4 (13.3–62.2) 5.9 (0.6–38.9) 73.1 (27.5–95.1) 5.5 (1.6–17.6) 64.6 (12.9–95.7) 16.3 (6.4–35.5)
Users with difficulties in the 
use of medicines
30.5 (12.7–56.8) 6.7 (0.7–43.2) 12.6 (2.1–49.0) 28.8 (11.4–54.8) 27.3 (2.6–84.1) 23.0 (10.7–42.8)
Specific groups 4.1 (0.5–24.6) 2.0 (0.1–21.6) 2.3 (0.3–14.0) 16.2 (6.3–35.5) 4.0 (0.4–32.5) 10.9 (4.5–24.0)
Available resources
Specific location 46.5 (23.6–70.9) 5.9 (0.6–38.9) 77.7 (33.5–96.0) 50.8 (27.6–73.7) 4.0 (0.4–32.5) 42.4 (22.4–65.3)
Registration system
Computerized system 34.3 (14.5–61.6) 2.0 (0.1–21.6) 73.1 (27.5–95.1) 53.6 (29.5–76.1) 68.6 (14.6–96.5) 45.1 (24.7–67.2)
Specific registration filed in the 
pharmacy
50.5 (26.7–74.1) 8.7 (1.0–47.0) 83.7 (43.3–97.2) 38.5 (18.1–63.8) 96.0 (67.5–99.6) 40.3 (21.5–62.4)
User medical record 42.4 (20.6–67.7) 6.7 (0.7–43.2) 13.1 (2.0–52.4) 65.6 (37.9–85.7) 72.7 (15.9–97.4) 48.2 (26.9–70.1)
Other 3.4 (0.5–21.2) – – 6.2 (1.9–18.0) 68.6 (14.6–96.5) 4.0 (1.3–11.4)
Qualification and training 49.7 (26,1- 73,4) 98.0 (78,4 - 99,9) 89.5 (54.2–98.4) 56.5 (30.5–79.3) 8.0 (1.1–40.5) 65.2 (41.6–83.1)
Interaction with the health team
Physicians 62.7 (35.9–83.5) 6.7 (0.7–43.2) 14.0 (2.4–51.7) 57.5 (31.9–79.6) 35.4 (4.3–87.1) 42.9 (23.7–64.4)
Nurses 54.6 (29.9–77.3) 8.7 (1.0–47.0) 14.0 (2.4–51.7) 57.9 (32.1–80.0) 35.4 (4.3–87.1) 43.0 (23.8–64.5)
Nutritionists 22.6 (7.1–52.6) 6.7 (0.7–43.2) 5.7 (0.7–34.3) 36.6 (17.4–61.3) 31.4 (3.5–85.4) 26.8 (13.2–47.0)
Dentists 50.5 (26.7–74.1) 4.8 (0.4–41.5) 5.7 (0.7–34.3) 29.6 (12.2–55.8) 31.4 (3.5–85.4) 23.8 (11.1–43.9)
Other 12.2 (3.7–33.1) – 1.1 (0.1–11.1) 5.5 (2.4–12.2) 27.3 (2.6–84.1) 5.3 (2.5–11.2)
Source: PNAUM – Services, 2015.
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were found in the Southeast and Midwest. In the Northeast, the percentages of registration 
were negligible (2%; 8.7%; and 6.7%, respectively).
In Brazil, about half of the respondents reported that the pharmaceutical activities of clinical 
nature are offered to all users of the health unit. This was the most common answer in the 
Northeast region. In the Midwest, these activities are more often offered only to users who 
request them.
More than half of the interviewed pharmacists informed to have received some training.
According to Table 4, the provision of information by pharmacists about the use and storage 
of medicines at home, at the moment of delivery, varies between regions. The Midwest 
region stands out for providing these information, while the Northeast presents the lowest 
percentages. The significant majority of pharmacists states that they inform users on the 
use of medicines, and just over half informs on storage at home. Thus, the provision of 
information on use surpasses information on storage at home, which may indicate that 
pharmacists disregard the users’ lack of information  about the care required to preserve 
the quality of the medicine.
Table 5 shows that, in Brazil, only about 1/3 of respondents reported participating in 
other activities carried out in the health unit. In general, the participation of pharmacists 
in these activities varies between regions. The Midwest presented the lowest percentage 
of participation of pharmacists in other activities in the health unit. Despite this, the 
percentages of participation in activities between them were more expressive when 
compared to other regions, except regarding the prevention and control of obesity. The 
Northeast is the region where pharmacists are less involved in family planning activities, 
and not at all in physical activity programs. 
The fact that activities of prevention and control of obesity and those to encourage physical 
activities have less participation of pharmacists draws attention, as they are the ones that 
least require the use of medicines for being more related to lifestyle. However, we observed 
in Brazil a relevant participation of pharmacists in activities that involve other sectors and 
the community itself (Table 5), except in the Northeast. Such activities could be closer to 
health promotion. 
Table 4. Information provided by pharmacists on the use and storage of medicines at the time of dispensing in primary health care, according 
to the regions of Brazil. National Survey on Access, Use and Promotion of Rational Use of Medicines, 2015. (n = 285)
Dimension/Variable
North Northeast Midwest Southeast South Brazil
% (IC95%) % (IC95%) % (IC95%) % (IC95%) % (IC95%) % (IC95%)
Information on the use of medicines
Always 93.1 (81–97.7) 71 (24.1–95.0) 97.6 (84.1–90.7) 76.1 (51.6–90.5) 82.3 (53.3–95) 79.5 (62.8–89.9)
Repeatedly – 24.3 (3.2–75.6) 2.4 (0.3–15.9) 2.2 (0.9–5.3) 3.6 (0.8–13.9) 4.2 (1.5–11.4)
Sometimes 3.6 (1.1–11.0) 0.9 (0.1–7.8) – 9.6 (3.9–22.1) 14.2 (3.0–47.0) 8.4 (3.0–17.1)
Rarely 3.2 (0.5–19.8) 0.9 (0.1–7.8) – 12.1 (1.9–49.5) – 7.6 (1.2–35.7)
Never – 2.8 (0.5–14.5) – – – 0.2 (0.1–1.1)
Information on the storage of medicines
Always 59.2 (43.3–73.4) 23.5 (5.7–60.9) 67.7 (46.3–86.4) 58.6 (39.8–75.2) 53.8 (32.5–73.7) 55.8 (43–67.8)
Repeatedly 2.4 (0.3–15.5) 8.7 (2.0–31.1) 5.9 (3.0–11.3) 0.2 (0–1.8) 4.7 (2.6–8.2)
Sometimes 18.0 (9.0–32.6) 47.5 (11.1–86.8) 5.7 (2.0–14.9) 34.6 (18.1–56.0) 36.6 (18.8–59.1) 32.4 (20.3–47.5)
Rarely 5.7 (2.0–14.9) 24.3 (3.2–75.6) 8.5 (2.1–29.2) 0.6 (0.2–1.6) 1.6 (0.2–11.1) 3.8 (1.2–11.4)
Never 14.7 (6.1–31.3) 4.7 (1.1–17.4) 9.4 (3.5–23.1) 7.7 (1.1–38.7) 3.2 (1.4–7.2)
Source: PNAUM – Services, 2015.
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DISCUSSION 
Although still incipient, activities of clinical nature occur in the Brazilian primary health 
care, but in unequal proportions in all regions. 
In general, these activities require minimal resources for their accomplishment: conditions 
that ensure privacy in the pharmacist/patient therapeutic relationship, criteria for the 
provision of the service, documentation and training, among others6,11,15,21,24.
In this study, most pharmacists who claimed performing activities of clinical nature also 
stated not disposing of a specific place to perform them, which is an essential condition to 
the preservation of privacy and confidentiality in the activities with the user. Privacy can be 
defined as the personal desire to keep secret facts closely linked to the person; the secrecy of 
information ensures confidentiality. The assurance of privacy and confidentiality contributes 
to the therapeutic relationship to be more interactive and resolutive6,17.
We were able to identify a set of difficulties to the performance of these activities, according 
to the interviewed pharmacists. The reasons, in general, refer to structural problems or 
excess of activities under the responsibility of the pharmacist. These same problems were 
also reported by those who declared to perform activities of clinical nature concomitantly 
with other functions.
Table 5. Participation of pharmacists in other activities in primary health care, according to the regions of Brazil. National Survey on Access, 
Use and Promotion of Rational Use of Medicines, 2015. (n = 285)
Dimension/Variable
North Northeast Midwest Southeast South Brazil
% (IC95%) % (IC95%) % (IC95%) % (IC95%) % (IC95%) % (IC95%)
Participation in meetings of the health team
Always 46.9 (32–62.3) 19.4 (4.3–56.1) 26.2 (12.5–46.9) 43.6 (28.5–59.9) 41.9 (23.6–62.6) 39.6 (29.2–51.0)
Repeatedly 4.6 (1.1–16.7) – – 5.4 (2.3–12.2) 2.1 (0.4–9.8) 3.8 (1.8–7.9)
Never 21.4 (10.8–38.0) 4.7 (1.3–15.8) 23.5 (9.2–48.2) 18.3 (9.8–31.4) 30.6 (12.8–57.0) 19.7 (12.7–29.2)
Sometimes 3.5 (0.8–13.9) 47.8 (11.3–86.9) 26 (9.2–54.9) 8.2 (3.4–18.5) 1.9 (0.3–12.9) 12.3 (6.1–23.0)
Rarely 23.6 (13.3–38.5) 28.1 (4.7–75.7) 24.3 (11.5–44.3) 24.6 (10.3–48.0) 23.5 (10.4–44.9) 24.7 (14.1–39.5)
Participation in other activities in the health units
No 47.7 (32.9–93.0) 55.2 (15.8–89) 74.4 (54.1–87.8) 72.4 (59.0–82.7) 45.8 (25.8–67.1) 65.9 (55.5–75.0)
Yes 52.3 (37.0–67.1) 44.8 (11–84.2) 25.6 (12.2–45.9) 27.6 (17.3–41.0) 54.2 (32.9–74.2) 34.1 (25–44.5)
Activities
With other sectors (education, social 
services, environment etc.)
63.4 (39.6–82.1) 36.4 (6.7–82.0) 71.3 (41.2–89.9) 61.9 (40.2–79.7) 67.7 (36.1–88.6) 61.2 (30.2–56.5)
Organizational activities of the community 44.1 (23.9–66.4) 12.0 (1.3–59.1) 77.6 (51.1–92) 37.6 (21.6–56.8) 40.4 (18.8–66.4) 38.8 (27–52.2)
Joint effort to solve problems in the 
community
67.8 (44.6–84.6) 41.4 (7.8–85.6) 89.1 (69.5–96.7) 32.1 (18.5–49.6) 44.5 (20.5–71.3) 42.9 (30.2–56.5)
Preservation of nature 21.4 (8.1–45.6) 2.1 (0.2–17.5) 36.6 (12.7–69.7) 24.0 (11.9–42.5) 38.0 (15.7–66.9) 25.8 (15.9–38.9)
Prevention and control of obesity 47.4 (26.4–69.4) 5.1 (0.5–35.1) 17.9 (3.5–56.9) 28.7 (15.0–47.9) 45.4 (21.2–72.0) 30.5 (19.8–43.9)
Physical activities 17.8 (5.6–44.2) – 25.1 (7.1–59.8) 22.2 (11.6–38.5) 31.3 (13.1–57.9) 21.9 (13.8–33.0)
Prevention and control of hypertension 
and diabetes
80.2 (54.9–93.1) 39.4 (7.4–84.1) 90.9 (71–97.6) 75.0 (37.6–91.0) 71.2 (37.6–91.0) 71.5 (53.8–84.4)
Environmental control of diseases 
(e.g. combating dengue fever)
47.9 (27.0–69.7) 93.7 (73.6–98.8) 90.7 (68.7–97.8) 30.3 (16.9–48.2) 46.0 (21.6–72.4) 47.1 (33.5–61.2)
Prevention of cervical and uterine cancer 52.3 (30.4–73.3) 25.3 (4.0–73.1) 75.1 (45.6–91.6) 31.7 (18.0–49.5) 53.1 (26.8–77.8) 40.9 (28.6–54.4)
Prevention of prostate cancer 37.4 (18.7–60.7) 25.3 (4.0–73.1) 65.6 (35.1–87.1) 28.3 (15.4–46) 56.1 (28.9–80.1) 38.3 (26.3–51.8)
Prevention of sexually transmitted diseases 65.2 (41.4–83.2) 83.8 (40.5–97.5) 86.9 (55.7–97.2) 53.1 (32.9–72.3) 58.6 (30.6–81.9) 61.3 (46.2–74.5)
Family planning 69.8 (46.8–85.9) 9.2 (1.7–37.7) 42.8 (16.3–74.2) 38.4 (22.6–57.0) 33.8 (14.7–60.2) 36.3 (25.2–49.0)
Source: PNAUM – Services, 2015.
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The incipient institutionalization of pharmaceutical activities of clinical nature in the primary 
healthcare of SUS, associated with the deficiencies regarding the implementation of PNAF 4, 
still limited in its guidelines, can explain the poor development of these activities. Although 
most pharmacists recognize them as important, only few are currently performing them. 
In several countries, an important aspect of the activities of clinical nature concerns the 
organization of services with this purpose and the character of exclusive dedication by the 
person who performs these activities. Pharmacists who engage in these services are not 
authorized by the health systems or class authorities to carry out other activities, to prevent 
conflicts of interest, as well as to optimize the work they perform11,21,24.
Difficulties identified regarding the resources needed to carry out these activities, 
in the Brazilian primary health care, indicate some improvisation that demands efforts 
by professionals, besides not having criteria that allow rationalizing the provision of those 
activities on health services. 
In several countries, qualification and training are requirements for performing any pharmaceutical 
activity of clinical nature. Both initial and periodical training are needed, considering the 
uniqueness of required skills and abilities5,6,11,23,27. Furthermore, the unmet need of specific training 
of the pharmacists hinders the understanding of the philosophical principles established for the 
activities of clinical nature, namely: the values, responsibilities, functions and activities, as well 
as the modus operandi of the process of care and management of these activities6,13,19,27. 
Concerning the criteria for providing the service, according to the literature, the most used 
ones consider patients with higher risk of experiencing drug therapy  problems and who 
present chronic medical conditions. This strategy directs resources and efforts to care for 
groups in which the impact of pharmaceutical interventions are larger6,11,24,27.
In this study, it was not possible to deepen the analysis of the various registration procedures 
of the activities of clinical nature. We observed that, in Brazil, the percentages of registration 
of the three modalities were very close, and it called our attention that, despite the Northeast 
being the region that most declared performing activities of clinical nature, the percentages 
of registration of these activities were insignificant there. 
It should be stressed that the specific registration filed in the pharmacy may hinder the 
circulation of information among the professionals involved in the user’s care. The absence 
of registration indicates a low degree of institutionalization of these activities according to 
the philosophical premises required for a practice related to care, to meet the drug therapy 
needs of health services’ users6,17.
The registration of pharmaceutical interventions and the exchange of information among 
the professionals of the health team can contribute to the promotion of the safe and rational 
use of medicines. The registration of pharmaceutical activities of clinical nature systematizes 
the monitoring of the drug therapy employed by users and enables to evaluate  the need, 
safety, and effectiveness of the use of medicines, which provides more favorable results 
during the drug therapy6,18.
The participation of different health professionals – among which is the pharmacist – in 
clinical meetings usually indicates a recognition, by the health team, of the place of each 
professional in the care provided to users. Interaction with other professionals in the health 
team occurs in several models of clinical pharmaceutical practice and it is recommended6,12,19.
The philosophy of pharmaceutical care 2,6,17 reinforces the need for this interaction, for 
understanding that it contributes to ensure the completeness of care. The interaction between 
professionals is essential for all the required resources and expertise to be available to solve 
the population’s health problems. Furthermore, care is also based in different interdisciplinary 
decision-making processes and on the complementarity of knowledge to promote the most 
appropriate care to people6. 
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In this study, the names assigned to the activities of clinical nature revealed that the 
expressions “pharmaceutical guidance” and “pharmaceutical care” are the most used 
between pharmacists who performed these activities. However, apart from the issue of 
naming, we identified in the respondents an understanding that the activities they carry 
out during dispensing would correspond to pharmaceutical activities of clinical nature. 
This may be related to the insufficient conceptual and philosophical discussion in Brazil on 
pharmaceutical care and to the disputes of the scientific field2,19,16,22,26.
In the Northeast, the fact that all pharmacists who claimed to perform activities of clinical 
nature also declared performing the dispensation of medicines stands out. Given that 
dispensing includes guidance to users, it is possible that these pharmacists understand that 
the activities of clinical nature they claim to perform are mainly dispensing, because the 
name most often attributed to those activities was “pharmaceutical guidance.” 
Unlike the other regions, in the Midwest, dispensing was an activity reported by 32.9% of 
the pharmacists who claimed to develop activities of clinical nature. Since, in this region, 
the name most commonly attributed to the activities of clinical nature was “pharmaceutical 
consultation,” there may be, between these pharmacists, a clearer understanding of the 
nature of these activities and of dispensing. 
Dispensing requires pharmacists to report, guide, and educate on the use of medicines. 
Such activity, particular to this professional – essential to the proper use of this technology 
– does not necessarily imply that the pharmacist who practices dispensing should take 
responsibility for the results of the patient’s drug therapy, which is required from those who 
perform the pharmaceutical care2,6,12,15,17,21.
In the Brazilian case, the choice for a definition of pharmaceutical care that includes the 
activities of dispensing, guidance, and education in health can hinder the understanding of 
what characterizes what is proper or innovative regarding activities of clinical nature12,16,17,19.
In this study, we observed little participation of pharmacists in educational and health-related 
activities in primary health care services, which indicates that this professional is not yet 
well integrated into the health team and that pharmaceutical services are still isolated from 
other health actions. The involvement of pharmacists in less medicalized activities8 can be 
related to the maintenance of the centrality of medicines in pharmaceutical practices.
With a view to promote the rational use of medicines, strategies that reduce  the morbidity 
and mortality related to these technologies may be clinical in nature and may also include 
collective educational activities20. However, these actions cannot be confused with the 
pharmaceutical activities of clinical nature observed in other countries2,17,19.
This study raises some questions not yet investigated and others that require further 
development. It is important to investigate how the implementation of these activities 
occurred in pharmaceutical policies of other countries and in Brazil, which were the 
structuring elements of these clinical activities, and how the working process of pharmacists 
performing such activities in SUS takes place. We sought to identify the presence of 
philosophical elements, a process of care, and management aspects that could characterize 
what we decided to call, for the purposes of this study, pharmaceutical activities of clinical 
nature. However, it is necessary to signal the limitations of the results, which did not allow 
a better understanding of the regions and their pharmaceutical services, neither of the 
processes regarding the practices of clinical nature developed by the professional pharmacists. 
The confrontation of drug-related morbidity and mortality14 has contributed to the reorganization 
of pharmaceutical practices. Although important pharmaceutical policies in Brazil have established 
pharmaceutical care as a guideline, it is necessary to undertake efforts to institutionalize these 
clinical activities, ensuring proper infrastructure, qualification of professionals, funding, and 
assessment of the results so that pharmacists and public administrators are encouraged to offer 
such activities in SUS, promoting the implementation of PNAF regarding all its guidelines.
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